Landfar Bio-medicine Co., Ltd. (000504) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Landfar Bio-medicine Co., Ltd.

Why is Landfar Bio-medicine Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -3.29% and Operating profit at -234.48% over the last 5 years

With a growth in Net Profit of 145.42%, the company declared Very Positive results in Sep 25

ROCE(HY) Highest at -2.53%
OPERATING PROFIT(Q) Highest at CNY 9.69 MM
OPERATING PROFIT MARGIN(Q) Highest at 30.43 %

With ROE of -11.26%, it has a risky valuation with a 13.17 Price to Book Value

Over the past year, while the stock has generated a return of 49.45%, its profits have risen by 42.9%

Market Beating Performance

The stock has generated a return of 49.45% in the last 1 year, much higher than market (China Shanghai Composite) returns of 24.70%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Landfar Bio-medicine Co., Ltd. should be less than 10%
Overall Portfolio exposure to Retailing should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Landfar Bio-medicine Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Landfar Bio-medicine Co., Ltd.

49.45%

1.06

39.33%

China Shanghai Composite

24.7%

1.91

12.95%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-3.29%

EBIT Growth (5y)

-234.48%

EBIT to Interest (avg)

-7.20

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.69

Sales to Capital Employed (avg)

0.72

Tax Ratio

15.27%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

12.39%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

13.17

EV to EBIT

-85.08

EV to EBITDA

-190.32

EV to Capital Employed

-47.23

EV to Sales

21.65

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-11.26%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

24What is working for the Company

ROCE(HY)

Highest at -2.53%

OPERATING PROFIT(Q)

Highest at CNY 9.69 MM

OPERATING PROFIT MARGIN(Q)

Highest at 30.43 %

PRE-TAX PROFIT(Q)

Highest at CNY 11.49 MM

NET PROFIT(Q)

Highest at CNY 8.72 MM

EPS(Q)

Highest at CNY 0.03

-11What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 21.24 MM

NET SALES(9M)

At CNY 83.44 MM has Grown at -9.72%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.53 times

DEBT-EQUITY RATIO (HY)

Highest at -50.37 %

Here's what is working for Landfar Bio-medicine Co., Ltd.

Pre-Tax Profit

At CNY 11.49 MM has Grown at 288.49%

over average net sales of the previous four periods of CNY -6.1 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 8.72 MM has Grown at 334.54%

over average net sales of the previous four periods of CNY -3.72 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Profit

Highest at CNY 9.69 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Operating Profit Margin

Highest at 30.43 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at CNY 11.49 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 8.72 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.03

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Here's what is not working for Landfar Bio-medicine Co., Ltd.

Operating Cash Flow

Lowest at CNY 21.24 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Inventory Turnover Ratio

Lowest at 1.53 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Net Sales

At CNY 83.44 MM has Grown at -9.72%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Debt-Equity Ratio

Highest at -50.37 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio